The CMS Innovation Center has debuted a new model to encourage the use of technology to treat chronic diseases, which could be a boon for health tech companies that have struggled with reimbursement.
Explore the latest advancements in oncology, including biomarkers and targeted therapies, enhancing patient care at Tennessee Oncology and Vanderbilt-Ingram Cancer Center. Cancer treatment has evolved ...
Six states will be testing a new model, developed by the Centers for Medicare and Medicaid Services (CMS), for the federal health program Medicare in 2026. At the end of June, CMS announced the new ...
Analysis of Tumor Microenvironmental Features Between Primary and Synchronous Liver Metastases From Patients With Colorectal Cancers Using a Deep Learning Algorithm We identified a cohort of 1,201 ...
Some senior officials who have taken the test have been asked whether they said anything negative about the F.B.I. director, Kash Patel. By Adam Goldman Reporting from Washington Typically, the F.B.I.
This important study presents single-unit activity collected during model-based (MB) and model-free (MF) reinforcement learning in non-human primates. The dataset was carefully collected, and the ...
Add Yahoo as a preferred source to see more of our stories on Google. FDA Commissioner Martin Makary on Thursday announced a move away from animal-based drug testing in favor of human-based methods ...
The U.S. Food and Drug Administration said on Thursday that it will be phasing out the animal testing requirement for monoclonal antibody therapies and other drugs, replacing it with more ethical ...
April 10 (UPI) --The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial intelligence, when developing monoclonal antibody therapies and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results